IL17A and psoriasis: In the IMQ-induced mouse model of psoriasis, pharmacological ablation of TRPV1+/Nav1.8+ sensory neurons inhibited the release of IL-23 from dermal DC and subsequent IL-17 release by γδ T cells, resulting in reduced recruitment of inflammatory cells (29).